NasdaqCM - Nasdaq Real Time Price USD

Onconetix, Inc. (ONCO)

0.1140 -0.0081 (-6.63%)
As of 10:29 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
58.4650
58.4650
--
--
--
Cost of Revenue
1,185.6300
1,185.6300
--
--
--
Gross Profit
-1,127.1650
-1,127.1650
--
--
--
Operating Expense
16,720.0840
16,720.0840
13,481.2400
3,417.3340
1,622.0690
Operating Income
-17,847.2490
-17,847.2490
-13,481.2400
-3,417.3340
-1,622.0690
Net Non Operating Interest Income Expense
-671.6250
-671.6250
--
--
22.6030
Other Income Expense
-18,903.4130
-18,903.4130
61.4100
--
--
Pretax Income
-37,422.2870
-37,422.2870
-13,419.8300
-3,417.3340
-1,599.4660
Tax Provision
-12.5930
-12.5930
--
--
--
Net Income Common Stockholders
-37,409.6940
-37,409.6940
-13,516.1890
-4,044.7250
-2,159.3940
Diluted NI Available to Com Stockholders
-37,409.6940
-37,409.6940
-13,516.1890
-4,044.7250
-2,159.3940
Basic EPS
-2.19
--
-1.10
-0.37
-0.20
Diluted EPS
-2.19
--
-1.10
-0.37
-0.20
Basic Average Shares
17,111.3740
--
12,271.4490
10,913.7980
11,048.5870
Diluted Average Shares
17,111.3740
--
12,271.4490
10,913.7980
11,048.5870
Total Operating Income as Reported
-36,034.5950
-36,034.5950
-13,481.2400
-3,417.3340
-1,622.0690
Total Expenses
17,905.7140
17,905.7140
13,481.2400
3,417.3340
1,622.0690
Net Income from Continuing & Discontinued Operation
-37,409.6940
-37,409.6940
-13,419.8300
-3,417.3340
-1,599.4660
Normalized Income
-18,646.6971
-18,646.6971
-13,481.2400
-3,417.3340
-1,599.4660
Interest Income
--
--
--
--
22.6030
Interest Expense
671.6250
671.6250
--
--
--
Net Interest Income
-671.6250
-671.6250
--
--
22.6030
EBIT
-36,750.6620
-36,750.6620
-13,419.8300
-3,417.3340
-1,622.0690
EBITDA
-36,706.7250
-36,706.7250
-13,413.0780
-3,412.4440
-1,619.0130
Reconciled Cost of Revenue
1,185.6300
1,185.6300
--
--
--
Reconciled Depreciation
43.9370
43.9370
6.7520
4.8900
3.0560
Net Income from Continuing Operation Net Minority Interest
-37,409.6940
-37,409.6940
-13,419.8300
-3,417.3340
-1,599.4660
Total Unusual Items Excluding Goodwill
-18,769.3130
-18,769.3130
61.4100
--
--
Total Unusual Items
-18,769.3130
-18,769.3130
61.4100
--
--
Normalized EBITDA
-17,937.4120
-17,937.4120
-13,474.4880
-3,412.4440
-1,619.0130
Tax Rate for Calcs
0.0000
0.0000
--
--
--
Tax Effect of Unusual Items
-6.3161
-6.3161
--
--
--
12/31/2020 - 2/18/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

KA Kineta, Inc.
0.5900
-4.76%
 
ENSC Ensysce Biosciences, Inc.
0.5575
-0.20%
 
XCUR Exicure, Inc.
0.5125
-0.49%
 
SXTP 60 Degrees Pharmaceuticals, Inc.
0.2365
-2.39%
 
RNAZ TransCode Therapeutics, Inc.
0.4450
+1.16%
 
KPRX Kiora Pharmaceuticals, Inc.
0.4935
-2.43%
 
NBY NovaBay Pharmaceuticals, Inc.
0.0752
-2.72%
 
PHGE BiomX Inc.
0.3220
-5.27%
 
EVLO Evelo Biosciences, Inc.
0.0442
0.00%
 
FWBI First Wave BioPharma, Inc.
2.8151
-6.78%